Exits
German Equity Partners BV sells Spectro to Ametek
ECM has advised a consortium of institutional investors led by German Equity Partners BV in thesale of Spectro to the American publicly quoted Ametek Inc.
3i sells Reddot to Nasdaq listed Hummingbird
3i has announced the sale yesterday of its portfolio Reddot Solutions for a cash consideration of EUR 39.1m to Nasdaq listed Hummingbird.
Successful IPO for Revus Energy
Revus Energy, the independent Norwegian upstream company, has achieved a successful flotation of its business on the Oslo Stock Exchange with trading of the company's ordinary shares due to commence today.
Logic Control sold to Sage Group
The Sage Group Plc has agreed to acquire Logic Control S.A., a vendor of business management software in Spain, for an enterprise value of approximately £55m, paid in cash. The deal represents an exit for InvestIndustrial, Sagitta and B&S. The acquisition...
Graphite sells LS Group to SIG for £47m
Graphite Capital, the UK mid-market private equity specialist, has sold its majority shareholding in LS Group (LS) to SIG, the leading supplier of insulation, roofing and commercial interiors products. The deal values LS, the bespoke door manufacturer,...
Sigefi Ventures profits from 2 exits in 2005
Sigefi Ventures, which is in charge of the Siparex Group’s venture capital activity, realized EUR 8.5m in capital gains over the first five months of 2005. The capital gains came from the “FCPI” innovation funds and the fund Sudinnova II, all of...
Meiosys sale success for large VC syndicate
IBM has acquired Meiosys, a privately held company based in Palo Alto and Toulouse. Meiosys provides unique software technologies that enable applications to be dynamically moved from one server or set of servers to others without disruption. Financial...
Hg sells Trados for $60m
HgCapital has announced the sale of Trados Incorporated, the global market leader in globalisation software to the translator and corporate enterprise market to SDL Plc.
Barclays Ventures exits System C Healthcare on AIM
Barclays Ventures has sold its22% stake in System C Healthcare, as part of a £27.3m share placingand admission to AIM.